WAG=Rij rat strain has been suggested as an animal model for the study of inherited human medullary thyroid carcinoma (MTC), due to its high incidence of spontaneous C-cell thyroid tumours. Although the role of the Ret proto-oncogene mutations, as responsible for human MTC, is well established, nothing has been published concerning this putative animal model. Based upon the previously reported rat Ret sequence, exons 10, 11, 13, 14, 15, and 16, known to carry activating mutations in humans, have been analysed in the WAG=Rij rat by PCR, single strand conformational polymorphism (SSCP) and direct sequencing. Neither the germline nor MTC samples showed any Ret sequence difference in the exons when analysed in comparison to a non-MTC-susceptible rat strain. Our results indicate that Ret exons relevant in humans are not involved in WAG=Rij rat MTC, as expected, and this questions the validity of this strain as a model for the human disease, and suggests there must be additional mechanisms for the genesis and progression of rat MTC.
Human medullary thyroid carcinoma (MTC) is a neoplasm with its origin in C-cells that may occur sporadically (75%), or as a component of familial cancer syndromes (25%) which present an autosomal dominant mode of inheritance. Two of the inherited forms are associated with the development of multiple endocrine neoplasia . MEN-2A is characterized by the triad of MTC, phaeochromocytoma, and parathyroid hyperplasia, whereas MEN-2B is characterized by similar features except for the absence of parathyroid hyperplasia.
Finally, the third inherited form, familial medullary thyroid carcinoma (FMTC), has MTC as its only known phenotype (see DeLellis 1995 , Goodfellow & Wells 1995 . Recently all these syndromes have been found in association with germline mutations of the Ret proto-oncogene (Donis-Keller et al. 1993 , Santoro et al. 1995 , Pasini et al. 1996 . The Ret protooncogene is a member of the receptor tyrosine kinase (RTK) family with which it shares a highly conserved intracellular domain. The Ret extracellular portion is involved in the formation of a complex with two other proteins, the glial cell-line derived neurotrophic factor (GDNF) and the GDNF receptor-alpha (GFRA1), resulting in the activation of the intracellular TK activity.
Ret mutations have been found in both inherited and sporadic human MTCs. Missense mutations affecting conserved cysteine codons adjacent to the transmembrane domain of the Ret proto-oncogene have been identi ed in the germline DNA of patients with MEN-2A and FMTC, while mutations in the tyrosine kinase domain of the Ret receptor have been associated with MEN-2B and FMTC phenotypes. The majority of those patients carry a germline point mutation affecting one of ve cysteine residues encoded by exon 10 (codon 609, 611, 618, or 620) or 11 (codon 634). In a few FMTC families, point mutations involving noncysteine codons in exon 13 (codons 768, 790, and 791), 14 (codon 804), or 15 (codon 891) have been reported. MEN-2B patients carry point mutations in exon 16 (codon 883 or 918) (Donis-Keller et al. 1993 , Pasini et al. 1996 , Marsh et al. 1997 .
For all inherited forms of human MTC, several successive histopathological steps have been described, including diffuse C-cell hyperplasia and focal C-cell hyperplasia whose growth leads to malignant MTCs (Wolfe et al. 1973) . In rats, different authors have also described the complete spectrum of proliferative abnormalities of the C cells, including mild and severe diffuse C-cell hyperplasia, focal C-cell hyperplasia, and medullary thyroid carcinoma (DeLellis et al. 1979 , MartẂn-Lacave et al. 1999 . As these ndings were essentially identical to those seen in the familial form of human MTC, they indicated that rats could be a useful model for studying the processes of neoplastic development and progression.
The incidence of spontaneous C-cell tumours in the thyroid gland of different strains of rats ranged between 16% and 40% (Lindsay et al. 1968 ); but there is a particular strain, the WAG=Rij rat, in which the frequency when aging reaches 50% (Boorman et al. 1972) , 68% (Lausson et al. 1995) or even 75% (our group, unpublished data). In old WAG=Rij rats, the three speci c stages of MTC progression are remarkably similar to the histopathological changes occurring in the familial form of the human disease. However, no MEN-like association seems to exist, such as a coexistence with phaeochromocytoma (Boorman et al. 1972) or parathyroid lesions (Lindsay & Nichols 1969) . The WAG=Rij rat could thus be a model of the human FMTC in which the successive histopathological steps conducting to MTC have been studied (Kakudo et al. 1984 , Khattab et al. 1989 , Nelkin et al. 1989 , Ouazzani et al. 1994 , Lausson et al. 1995 . However, unlike its human counterpart, Ret analysis in rat MTC has not been reported so far.
We have recently described the complete sequence of the Ret proto-oncogene in the germline of the Sprague-Dawley rat (Matera et al. 2000) (EMBL accession numbers from AJ298999 to AJ299017). The rat Ret protooncogene is highly conserved with respect to the mouse (92%) and the human (84%) homologous genes, and the similarity is higher for the intracellular domain than for the extracellular domain. On the other hand, codons involved in mutations associated with inherited forms of human MTC are unchanged in the three species considered. Taking advantage of the availability of the rat Ret proto-oncogene complete nucleotide sequence, we have analysed all the regions implicated in the development of the human MTC in the germline and in C-cell carcinoma tissue of the WAG=Rij rat strain. The aim of the present study was to investigate whether or not the high incidence of C-cell tumours in the WAG=Rij rat is due to Ret proto-oncogene germline and=or somatic mutations, as happens in humans. In such a case, the WAG=Rij rat would be an interesting model for the study of molecular changes related to tumour origin and neoplastic progressing and, therefore, for gene therapy and pharmacological investigation.
Materials and methods

Materials
Two-month-old male and female WAG=Rij rats were imported from The Central Animal Laboratory, University Central Utrecht (The Netherlands). Successive series of crosses were carried out in order to obtain a statistically representative number of specimens to con rm the high rate of spontaneous C-cell tumours described in the literature for this strain. The animals were housed in Makrolon type IV cages in groups of ve rats at the Animal Service of the Medical School of Seville, maintained under speci c pathogen-free (SPF) conditions and given tap water and laboratory diet ad libitum. Standard food was purchased from B&K Universal Ltd. (North Humberside, United Kingdom). The animals were housed at a temperature of 23 § 1¯C with relative humidity of 55 § 5% in a 12=12 light=dark cycle. Ventilation was between 12 and 15 air changes per hour.
Methods
The sacri ce of the animals was performed by intraperitoneal injection of sodium pentobarbitone (200 mg=kg). The rats were subjected to exhaustive necropsy and histopathological analysis of thyroid and other neuroendocrine tissues. Animals bearing any histopathological alteration in other tissues were discharged.
For Ret proto-oncogene sequence analysis of the germline, blood samples from 3month-old WAG=Rij rats were taken. DNA was isolated from haematological cells by the standard phenol chloroform method. Ret regions candidate to carry mutations involved in WAG=Rij rat MTC development (exons 10, 11, 13, 14, 15 and 16) were PCRampli ed (Fig 1) . Based upon the recently published Sprague-Dawley rat Ret sequence (Matera et al. 2000) , intronic anking primers for these exons were designed.
Primer sequences and PCR conditions shown in Table 1 were used. Finally, PCR fragments were subjected to direct DNA sequencing and the WAG=Rij Ret sequence was aligned and compared to the non-MTC susceptible Sprague-Dawley Ret sequence.
For the somatic mutation analysis, 24-month-old WAG=Rij rats were sacri ced and their thyroids were isolated. The samples were xed in either 10% formalin or 2.5% glutaraldehyde and embedded in paraf n or Spurr resin, respectively. For diagnostic evaluation, 5 mm tissue sections were cut from each paraf n block and stained with haematoxylin eosine and immunoperoxidase (anti-thyroglobulin, 1:400 dilution; and anti-calcitonin, 1:1000 dilution; DAKO, Denmark). Semithin sections (0.5 mm) were cut from each Spurr resin block and routinely stained with toluidine blue. The histopathological criteria used to evaluate the different proliferative disorders of C-cells are those of DeLellis et al. (1979) , Capen and Martin (1989) , and Greaves and Faccini (1992) . Twenty-ve C-cell carcinomas were selected for this study (Fig 2) . DNA was isolated by the standard phenol chloroform method. Exons 10, 11, 13, 14, 15 and 16 were PCRampli ed, and mutation analysis was carried out by single strand conformational polymorphism (SSCP) and DNA sequencing, according to a previously published strategy and conditions .
Results
In order to analyse the potential presence of germline mutations, exons containing all codons more likely to carry a Ret activating mutation (exons 10, 11, 13, 14, 15 and 16) were PCR-ampli ed and compared to the same PCR ampli cation products obtained from the Sprague-Dawley rat. All WAG=Rij PCR fragments for the studied exons exhibited the expected size (see Table 1 ) determined by their Sprague-Dawley counterparts. Moreover, PCR fragments of the WAG=Rij Ret proto-oncogene were subjected to direct sequencing and aligned with the corresponding ampli cation products obtained from the Sprague-Dawley. None of the six exons homologous to those involved Somatic mutation analysis was carried out by applying a PCR-SSCP approach to Ret exons 10, 11, 13, 14, 15 and 16 of each tumour sample, followed by direct sequencing of those PCR products which showed abnormal migrating bands. Although several SSCP conditions were carried out for each exon, none of the PCR fragments showed altered migrating patterns in any of the 25 rat MTC samples analysed.
Discussion
In contrast to the low frequency of human MTC described in the literature (Rosai et al. 1992) , spontaneous C-cell carcinoma appears with a distinguished higher frequency in rats. In particular, the C-cell carcinoma highly susceptible WAG=Rij rat strain presents the highest frequency for this malignancy, reaching 50% (Boorman et al. 1972) .
On the other hand, the role of the Ret proto-oncogene in human MTC has already been established (see Komminoth 1997 for a review). However, no similar studies have been carried out so far in the rat, despite the fact that several authors have suggested this rat strain as a model for the study of the origin and progression of the familial form of human MTC (Boorman & Hollander 1976 , DeLellis et al. 1979 , Lausson et al. 1995 . Many papers have already reported Ret codons and residues involved in the three known types of human syndromes (MEN 2A  and 2B , and FMTC) that present inherited MTC (Donis-Keller et al. 1993 , Pasini et al. 1996 , Marsh et al. 1997 .
On the basis of the recently published, complete sequence in the Sprague-Dawley rat (Matera et al. 2000) , we presently report the mutational analysis of the Ret protooncogene in the spontaneous MTCdeveloping WAG=Rij rat. None of the six exons candidate to carry activating mutations of Ret proto-oncogene presented changes in the nucleotide sequence either in the germline or in the MTC tissues studied.
The lack of mutations might indicate that the high incidence of MTCs in the WAG=Rij rat is not related to any human FMTC-like homologous syndrome. This was unexpected, considering the high similarity reported for the Ret proto-oncogene in the species described so far (Iwamoto et al. 1993 , Schuchardt et al. 1995 , Marcos-Gutié rrez et al. 1997 , Matera et al. 2000 , especially concerning the regions potentially involved in the oncogenic activation of the Ret protein. Moreover, human and rat medullary carcinomas of the thyroid have similar morphologic features, at both the light microscopic and ultrastructural levels (Boorman & Hollander 1976) . This study is the rst molecular analysis of the Ret proto-oncogene in rat spontaneous MTCs. The molecular characterization of the WAG=Rij rat as an animal model for MTC is of prime importance in understanding the molecular changes related to tumour genesis and progression. It has been described that the WAG=Rij rat strain has elevated calcitonin mRNA levels in C-cells (Delehaye et al. 1989 ) and a loss of renal binding sites for calcitonin (Bouizar et al. 1987 ). This last alteration seems to be inherited in a Mendelian fashion . Delehaye et al. (1990) suggesting that the enhanced expression of the calcitonin gene in WAG=Rij rats is probably a consequence of some unknown mutation involved in the loss of renal calcitonin binding sites. As this loss of calcitonin binding sites happens through the rst month of life, the supposed genetic alteration could be responsible for the initiation of the MTC carcinogenesis. Probably, as usually occurs in neoplastic processes, other genes are involved in the progression of these preneoplastic lesions to true C-cell carcinoma. According to this, the analysis of somatic mutations in WAG=Rij MTC tissues has been of great interest since Ret proto-oncogene could be associated to the progression of rat MTC. Nevertheless, our results con rm that the Ret proto-oncogene is not implicated in the progression of MTC in this rat strain.
Although we cannot absolutely exclude the possibility that mutations in other regions of the Ret proto-oncogene could participate in the carcinogenic process, it is improbable, considering the reportedly high similarity of this gene to its human counterpart (Matera et al. 2000) . Moreover, in human sporadic MTC, Ret mutations have been described affecting the same exons related to the inherited disease. These observations lead to the idea of the existence of other mechanisms for WAG=Rij MTC development, if Ret are really involved.
In conclusion, our data suggest that the Ret proto-oncogene is not involved in the development and progression of spontaneous MTCs of the WAG=Rij rat. They establish that the mechanism of MTC carcinogenesis in the rat is not the same as in the human, where the Ret proto-oncogene plays a crucial role and there are no evidences of loss of renal calcitonin binding sites. On the basis of the present results, the reputation of the WAG=Rij rat strain as a model of the familial form of human MTC must be questioned.
